GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » StemRIM Inc (TSE:4599) » Definitions » Price-to-Owner-Earnings

StemRIM (TSE:4599) Price-to-Owner-Earnings : 45.68 (As of Jun. 18, 2024)


View and export this data going back to 2019. Start your Free Trial

What is StemRIM Price-to-Owner-Earnings?

As of today (2024-06-18), StemRIM's share price is 円397.00. StemRIM's Owner Earnings per Share (TTM) ended in Jul. 2023 was 円8.69. It's Price-to-Owner-Earnings for today is 45.68.


The historical rank and industry rank for StemRIM's Price-to-Owner-Earnings or its related term are showing as below:

TSE:4599' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 46.98   Med: 90.85   Max: 103.63
Current: 46.98

During the past 7 years, the highest Price-to-Owner-Earnings of StemRIM was 103.63. The lowest was 46.98. And the median was 90.85.


TSE:4599's Price-to-Owner-Earnings is ranked worse than
63.03% of 165 companies
in the Biotechnology industry
Industry Median: 33.77 vs TSE:4599: 46.98

As of today (2024-06-18), StemRIM's share price is 円397.00. StemRIM's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2024 was 円-35.05. Therefore, StemRIM's PE Ratio for today is At Loss.

As of today (2024-06-18), StemRIM's share price is 円397.00. StemRIM's EPS without NRI for the trailing twelve months (TTM) ended in was 円-35.51. Therefore, StemRIM's PE Ratio without NRI for today is At Loss.

During the past 7 years, StemRIM's highest PE Ratio without NRI was 496.39. The lowest was 0.00. And the median was 210.74.


StemRIM Price-to-Owner-Earnings Historical Data

The historical data trend for StemRIM's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StemRIM Price-to-Owner-Earnings Chart

StemRIM Annual Data
Trend Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - 106.62

StemRIM Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 106.62 - - -

Competitive Comparison of StemRIM's Price-to-Owner-Earnings

For the Biotechnology subindustry, StemRIM's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


StemRIM's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, StemRIM's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where StemRIM's Price-to-Owner-Earnings falls into.



StemRIM Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

StemRIM's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=397.00/8.69
=45.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


StemRIM  (TSE:4599) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


StemRIM Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of StemRIM's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


StemRIM (TSE:4599) Business Description

Traded in Other Exchanges
N/A
Address
7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085
StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.

StemRIM (TSE:4599) Headlines

No Headlines